0 comments
8 forecasters
What hazard ratio will Novartis first report for the primary endpoint in the Lp(a) HORIZON clinical trial?
Latest estimate
0.867 HR
Disagreement Score55.75
Author:
Opened:Apr 22, 2026
Closed:Apr 22, 2026
Scheduled resolution:Aug 11, 2026
Spot Scoring Time:Apr 22, 2026
Include Bots:Yes